
### [MONDO:0011512](http://purl.obolibrary.org/obo/MONDO_0011512)
**Label:** Brooke-Spiegler syndrome

**Subclasses:** [MONDO:0007565](http://purl.obolibrary.org/obo/MONDO_0007565) (familial cylindromatosis), [MONDO:0011114](http://purl.obolibrary.org/obo/MONDO_0011114) (familial multiple trichoepithelioma), [MONDO:0012800](http://purl.obolibrary.org/obo/MONDO_0012800) (trichoepithelioma, multiple familial, 2), 

**Corr. equiv. classes:** [OMIM:612099](http://purl.obolibrary.org/obo/OMIM_612099), [Orphanet:211](http://www.orpha.net/ORDO/Orphanet_211), [Orphanet:867](http://www.orpha.net/ORDO/Orphanet_867), [OMIM:132700](http://purl.obolibrary.org/obo/OMIM_132700), [OMIM:601606](http://purl.obolibrary.org/obo/OMIM_601606), 

**Class expressions from DL-Learner:**

- [HP:0000006](http://purl.obolibrary.org/obo/HP_0000006) (Autosomal dominant inheritance) and [HP:0003581](http://purl.obolibrary.org/obo/HP_0003581) (Adult onset) and [HP:0008069](http://purl.obolibrary.org/obo/HP_0008069) (Neoplasm of the skin) 46.73%
- [HP:0003581](http://purl.obolibrary.org/obo/HP_0003581) (Adult onset) and [HP:0008069](http://purl.obolibrary.org/obo/HP_0008069) (Neoplasm of the skin) 45.00%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0003581](http://purl.obolibrary.org/obo/HP_0003581) (Adult onset) and [HP:0008069](http://purl.obolibrary.org/obo/HP_0008069) (Neoplasm of the skin) 45.00%
- [HP:0000951](http://purl.obolibrary.org/obo/HP_0000951) (Abnormality of the skin) 41.94%
- [HP:0001574](http://purl.obolibrary.org/obo/HP_0001574) (Abnormality of the integument) 41.72%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 41.02%
- Thing 41.02%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 41.02%
- [HP:0008069](http://purl.obolibrary.org/obo/HP_0008069) (Neoplasm of the skin) 36.38%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 32.93%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 32.79%
- [HP:0002671](http://purl.obolibrary.org/obo/HP_0002671) (Basal cell carcinoma) 32.13%
- [HP:0003581](http://purl.obolibrary.org/obo/HP_0003581) (Adult onset) 25.77%
- [HP:0003674](http://purl.obolibrary.org/obo/HP_0003674) (Onset) 22.40%
- [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) 21.89%


